View on Pubmed.gov 39570802 | View on doi.org 10.1158/0008-54...
Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers.
- Interventional Oncology, Johnson & Johnson Enterprise Innovation, Inc., Boston, Massachusetts.
- Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Medicine, National Taiwan University Cancer Center and College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Pathology, National Taiwan University Cancer Center and College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Surgery Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
- Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Abstract
Lung cancer is the most common cause of cancer mortality globally, and the prevalence of lung adenocarcinoma, the most common lung cancer subtype, has increased sharply in East Asia. Early diagnosis leads to better survival rates, but this requires an improved understanding of the molecular changes during early tumorigenesis, particularly in nonsmokers. In this study, we performed whole-exome sequencing and RNA sequencing of samples from 94 East Asian patients with precancerous lesions [25 with atypical adenomatous hyperplasia (AAH); 69 with adenocarcinoma in situ (AIS)] and 73 patients with early invasive lesions [minimally invasive adenocarcinoma (MIA)]. Cellular analysis revealed that the activities of endothelial and stromal cells could be used to categorize tumors into molecular subtypes within pathologically defined types of lesions. The subtypes were linked with the radiologically defined type of lesions and corresponded to immune cell infiltration throughout the early progression of lung adenocarcinoma. Spatial transcriptomic analysis revealed the distribution of epithelial cells, endothelial cells, fibroblasts, and plasma cells within MIA samples. Characterization of the molecular lesion subtypes identified positively selected mutational patterns and suggested that angiogenesis in the late-stage AIS type potentially contributes to tissue invasion of the MIA type. This study offers a resource that may help improve early diagnosis and patient prognosis, and the findings suggest possible approaches for early disease interception. Significance: Integrative analysis of multiomics data revealed coordination between immune and nonimmune cells during early progression of precancerous lesions to lung adenocarcinomas and shed light on the molecular characteristics of clinically defined subtypes.
References
Lung Cancer. 2011 Feb;71(2):137-43
Nat Rev Drug Discov. 2011 Jun;10(6):417-27
Am J Respir Crit Care Med. 2021 Nov 15;204(10):1180-1192
J Thorac Dis. 2017 Aug;9(8):2551-2559
Cited by 2 citations (total)
Journal Article
S100a4 + alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolism.
Electronic publication date July 14, 2025
Hong Huang [...] Le Zhang et al.
Lung cancer is preceded by premalignant lesions, and what factors drive this transformation and the potential regulatory mode in the...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
Substances
Copyright
©2024 The Authors; Published by the American Association for Cancer Research.